Guest Post: The Impending Reckoning on the U.S. Government’s Expansive Theory of Extraterritorial FCPA Liability

Today’s guest post is from Roxie Larin, a lawyer who previously served as Senior Legal Counsel for HSBC Holdings and is now an independent researcher and consultant on corruption, compliance, and white collar crime issues.

The U.S. Foreign Corrupt Practices Act (FCPA) is a powerful tool that the U.S. government has wielded to combat overseas bribery—not just bribery committed by U.S. citizens or firms, but also bribery committed by foreign nationals outside of U.S. territory. (The FCPA also applies to any individual, including a non-U.S. person or firm, who participates in an FCPA violation while in the United States, but this territorial jurisdiction is standard and noncontroversial.) The FCPA, unlike many other U.S. statutes, does not require a nexus of the alleged crime to the United States so long as certain other criteria are satisfied. For one thing, the statute applies to companies, including foreign companies, that issue securities in the U.S. In addition, the FCPA covers non-U.S. individuals or companies that act as an employee, officer, director, or agent of an entity that is itself covered by the FCPA (either a U.S. domestic concern or a foreign issuer of U.S. securities), even if all of the relevant conduct takes place outside U.S. territory.

In pursuing FCPA cases against non-U.S. entities for FCPA violations committed wholly outside U.S. territory, the agencies that enforce the FCPA—the Department of Justice (DOJ) and Securities and Exchange Commission (SEC)—have pushed the boundaries of this latter jurisdictional provision. They have done so in part by stretching to its limits (and perhaps beyond) what it means to act as an “agent” of a U.S. firm or issuer. (The FCPA provisions covering foreign “officers” and “employees” of issuers and domestic concerns are more straightforward, but also more rarely invoked. It’s rare for the government to have evidence implicating a corporate officer, and the employee designation doesn’t help unless the government is either able to dispense with notions of corporate separateness, given that foreign nationals are typically employed by a company organized under the laws of their local jurisdiction.) Until recently, the government’s expansive agency-based theories of extraterritorial jurisdiction had neither been tested nor fully articulated beyond a few generic paragraphs in the government’s FCPA Resource Guide. In many cases, foreign companies affiliated with an issuer or domestic concern have settled with the U.S. government before trial, presumably conceding jurisdiction on the theory that the foreign company acted as an agent of the issuer or domestic concern. (This concession may be in part because a guilty plea by a foreign affiliate is often a condition for leniency towards the U.S. company.) Hence, the government has not had to prove its jurisdiction over these foreign defendants.

But there was bound to be a reckoning over the U.S. government’s untested theories of extraterritorial FCPA jurisdiction, and the SEC and DOJ’s expansive theories are increasingly being tested in court cases brought against individuals who, sensibly, are more prone to litigating their freedom than companies are their capital. And it turns out that the U.S. government’s expansive conception of “agency” may be difficult to sustain in cases where the foreign national defendant—the supposed “agent” of the U.S. firm or issuer—is a low- or mid-level employee of a foreign affiliate, and even more difficult to sustain so where the domestic concern is only an affiliate and not the parent company. Continue reading

Guest Post: How President Ramaphosa Can Begin Rebuilding Public Trust in South African Government

Today’s guest post is from Larry Kirsch, an economist who is currently the Managing Partner of IMR Health Economics.

The South African government, like many governments around the world, faces daunting challenges due to the combination of the Covid-19 pandemic, economic collapse, and civil unrest. Addressing these problems requires not only decisive action by leaders, but also a sufficient reservoir of public trust. Without such trust, a leader’s call for civic sacrifice and solidarity may not receive the desired response. Unfortunately, South African citizens do not currently have much trust in their government. The leading international survey of trustworthiness, the Edelman Trust Barometer, reported this past January that trust in government among South Africans ranked lowest among the 28 countries surveyed—lower than Russia and Argentina and well below India and China.

Part of this lack of trust is due to chronically stressed economic conditions, as well as extreme structural inequalities. But citizens’ trust has been further undermined by South Africa’s endemic corruption. The corruption of former President Jacob Zuma and his closest cronies (especially the rapacious Gupta family) was well-documented in a a November 2016 report issued by the Office of the Public Protector, then headed by the highly-regarded Thuli Madonsela. That report, entitled The State of Capture, also emphasized the burden of corruption on everyday citizens, documenting, for example, how corruption had contributed to the dysfunctions in vital public services and state owned enterprises.

Will the relatively new government of President Cyril Ramaphosa be able to galvanize trust and obtain the degree of public support needed to deal with the grave threats facing South Africa? On the one hand, President Ramaphosa’s public statements, especially since the outbreak of the coronavirus in South Africa in early March, have been decisive, inclusive, and progressive, particularly in relation to the call for solidarity and the government’s commitment to the apportionment of healthcare, work, food, and other public support on the basis of need. But if President Ramaphosa truly wishes to begin a ”radical” restructuring process based on principles of fairness, social cohesion, and inclusive growth, he will have to deal squarely with the persistence of the culture of corruption, as well as with broader concerns about government openness and public accountability. And his stirring speeches have so far not included much information on how his administration intends to tackle these crucial issues.

One important element of a comprehensive strategy to rebuild the South African government’s integrity—and with it citizen trust in that government—would be for President Ramaphosa to personally back robust implementation of South Africa’s Promotion of Access to Information Act (PAIA). Continue reading

Guest Post: The Coalition for Integrity’s New Report on How To Ensure Oversight of U.S. Coronavirus Response Funds

Today’s guest post is by Shruti Shah, the President and CEO of the Coalition for Integrity, a civil society advocacy organization focused on corruption in the United States.

The U.S. Coronavirus Aid, Relief, and Economic Security Act (the CARES Act), enacted in late March to address the economic fallout from the coronavirus pandemic, provides over $2 trillion in various forms of relief, including over $600 billion for the Paycheck Protection Program (PPP), which provides loans to small businesses, and approximately $500 billion in additional discretionary Treasury Department loans. To ensure appropriate allocation of these funds, and to reduce the risks of corruption, fraud, and other forms of misappropriation, transparency and oversight are essential. Indeed, we have already seen the perils of a lack of transparency in awarding the PPP loans. Instead of prioritizing businesses who were in danger of failing without an injection of cash, many large chains and other well-funded companies received loans. Further, there are reports that businesses owned by members of Congress received money under the program, which raises conflict of interest concerns.

Unfortunately, the Trump Administration has resisted even relatively modest measures to assure transparency and accountability in the allocation of CARES Act funds. Treasury Secretary Steven Mnuchin previously announced that the names of PPP recipients would not be made public, making the misguided claim that the identity of PPP loan recipients is the companies’ confidential and proprietary information. But taxpayer have a right to know where their money is going (a principle the U.S. vigorously applies when sending foreign aid dollars overseas). Eventually Secretary Mnuchin relented to pressure to change course, and agreed to provide information regarding PPP loans in excess of $150,000. Yet the administration’s resistance to transparency and oversight has continued, as demonstrated by alarming reports that the Treasury Department’s Office of General Counsel has issued a legal opinion claiming that the Department has no obligation to provide key information to oversight officials, including the Pandemic Response Accountability Committee (PRAC), about the CARES Act’s PPP and discretionary business loan programs.

These reports underscore the importance of keeping up the pressure on Congress and the Administration to take appropriate steps to ensure genuine transparency and accountability in the allocation of pandemic response funds. Congress in particular may need to add new legal provisions to address the flaws in the oversight system. The Coalition for Integrity recently released a new report, entitled Oversight is Better than Hindsight: Anti-Corruption Recommendations for the CARES Act, which documents the current oversight gaps in the CARES Act and presents a set of recommendations on how best to close those gaps. These recommendations include, among others: increasing appropriations for oversight bodies, enacting for-cause removal protections for Inspectors General, enhancing whistleblower protections, requiring the Federal Reserve to comply with Sunshine’s Act meeting transcript or recording requirements, and appointing a chairperson to the Congressional Oversight Commission. The report also highlights a number of measures that the Administration can and should take, including better and more effective cooperation with the oversight bodies, creating a public-facing website with detailed information on contracts awarded under the stimulus program (as was done by the Recovery Accountability and Transparency Board, which oversaw the stimulus funding enacted in response to the 2007-2008 financial crisis), and ensuring more generally that agencies are responsive rather than resistant to requests and recommendations from oversight bodies.

Effective oversight is not a partisan political issue. Misuse of stimulus money will compound the country’s collective misery at a time when millions are already suffering from the grave health and economic effects of the pandemic. In this context, insufficient public transparency and a lack of full cooperation with oversight bodies should worry us all.

 

Guest Post: Ukraine’s Recipe for Fighting Judicial Corruption—Civil Society and International Experts

Today’s guest post is from Halyna Chyzhyk, a judicial reform expert at the Anticorruption Action Centre (ANTAC) in Kyiv, Ukraine:

Since Ukraine’s so-called Revolution of Dignity in 2013-2014, the country has substantially reformed its laws—both statutory and constitutional—on the judiciary and the status of judges. A new Supreme Court was created from scratch, the composition of Ukraine’s two judicial governance bodies—the High Qualification Commission of Judges (HQCJ) and the High Council of Justice (HCJ)—were completely changed, and several new anticorruption measures were enacted. For instance, judges are now required to submit electronic asset declarations, and failure to prove that the assets all derive from legal sources is grounds for dismissing a judge. Moreover, all judges are now obliged to pass an evaluation of their professional competence and integrity.

Despite these reforms, the judiciary remains one of the most corrupt and least trusted institutions in the country. One of the main problems is that the bodies most responsible for judicial appointment, removal, and self-governance—the HQCJ and the HCJ—do not take corruption seriously. In fact, these institutions are actively helping to protect and cover for corrupt judges, in some cases even using their authority to persecuting independent judges who try to expose judicial corruption. Consider, for example, the case of Larysa Holnyk, a judge from Poltava. In 2014, Judge Oleksandr Strukov, the head of the Poltava court, assigned Judge Holnyk a case concerning a potential conflict of interest of the Mayor of Poltava. The Mayor’s representative contacted Judge Holnyk to make an offer to settle the matter “amicably”—the clear implication was that the Mayor was offering some sort of improper inducement in exchange for making the case go away. Judge Holnyk not only refused the offer, but she reported the Mayor and his representative for attempted bribery. Since that time she has been suffering harassment from Judge Strukov, numerous court suits, and even physical attacks. However, the HCJ has refused to investigate Judge Strukov`s possible involvement in the corruption scheme, and has not punished him for persecuting Holnyk. Instead, the HCJ punished Judge Holnyk. Continue reading

Guest Post: How France Is Modernizing Its Criminal Procedure and Streamlining Its Resolution of Corporate Crime Cases

GAB is pleased to welcome back Frederick Davis, a lawyer in the Paris and New York offices of Debevoise & Plimpton and a Lecturer at Columbia Law School, who contributes the following guest post:

For approximately two decades, at least since 2000, France—a signatory to the 1997 OECD Anti-Bribery Convention — has had laws on the books that emulate the U.S. Foreign Corruption Practices Act (FCPA) by criminalizing bribes to foreign public officials. For most of that time, these laws were not effectively enforced: During the first 15 years after France prohibited foreign bribery, not a single corporation was convicted in France. The reasons for this—previously discussed on this blog by me and others—included the low maximum penalties applicable to corporations, imprecision in French laws relating to corporate criminal responsibility, lengthy investigations (often lasting over a decade) run by investigating magistrates, and the virtual absence of any possibility of a negotiated outcome. In the absence of French enforcement of its laws against foreign bribery, the U.S. Department of Justice (DOJ) took it upon itself to investigate and prosecute a number of French corporations for FCPA and other violations. These enforcement actions, which were typically resolved by guilty pleas or deferred prosecution agreements (DPAs), netted aggregate fines and other penalties of over $2 billion, not a penny of which was paid to France.

This situation provoked widespread discussion and debate in France, and eventually led to a number of changes in its criminal procedures. Among the most important were the creation, in 2013, of a National Financial Prosecutor’s office (PNF) with nationwide authority to prosecute a variety of financial crimes, and the adoption, in December 2016, of the so-called Loi Sapin II, which overhauled many of the criminal laws relating to corporate and financial crime, increasing corporate penalties, adopting a new settlement procedure called the Convention Judiciaire d’Intérêt Public (CJIP) closely modeled on the US DPA, and creating a French Anticorruption Agency (AFA) to supervise newly-mandatory corporate compliance programs and issue guidelines for corporate behavior. These reforms have already produced some impressive results, including major settlements (sometimes in cooperation with other countries like the US and UK) with large French and multinational companies (see, for example, here, here, and here).

An interview published this past April with Jean-François Bohnert, who has served since October 2019 as the National Financial Prosecutor, sheds some light on how France’s recent legal and institutional reforms are transforming its enforcement of its laws against foreign bribery and other complex corporate crime. In that interview, M. Bohnert understandably focused on his office’s successes; he was particularly proud of the number of cases his office had handled with a relatively small staff. But to my mind, by far the most interesting and important thing that came out of this interview was the fact that, of the 592 cases handled by the PNF in 2019, 81% were so-called “preliminary investigations” managed exclusively by the PNF, while only 19% were led by investigating magistrates. To someone unfamiliar with the French legal system, the significance of this statistic may not be readily apparent, but in fact it suggests an important change in the French approach to corporate misbehavior. Continue reading

Guest Post: Anonymous Companies Are Undermining Mexico’s Public Health

Today’s guest post is by Miguel Ángel Gómez Jácome, the Communications Coordinator at the Mexican civil society organization Impunidad Cero (Zero Impunity).

The COVID-19 pandemic has already affected millions of people. (As of the time this piece was initially drafted, around 2 million people had been infected; the exponential spread of the virus means that by the time this piece is published, that number is likely to be much higher.) And while Mexico has not yet been as severely impacted as other countries, official statistics (which likely understate the true prevalence) already report thousands of infections and hundreds of deaths. To confront this problem, Mexico, like other countries, will need to marshal its resources effectively. Unfortunately, though, Mexico’s ability to manage the COVID-19 epidemic is threatened by Mexico’s epidemic of embezzlement in the health sector, much of it facilitated by anonymous shell companies. This widespread corruption drains away vital public resources needed to combat public health emergencies like the COVID-19 pandemic.

In March 2020, two civil society organizations (Justicia Justa (Just Justice) and Impunidad Cero (Zero Impunity)), documented the extent of the problem in a research report entitled Fake Invoices: The Health Sector Epidemic. The research found that between 2014 and 2019, 837 shell companies issued 22,933 fake invoices to 90 health institutions across the country (in 30 of Mexico’s 32 states, as well as the federal government), ultimately embezzling a total of over 4 billion pesos (roughly $176 million US dollars) from the health sector—an amount that could have paid for around 80,000 hospital beds or between 3,400 and 6,900 ventilators. (To put this in context, Mexico currently has 5,000 ventilators in the whole country, and the government is looking to acquire 5,000 more.) And the problem is only getting bigger: According to Mexico’s Tax Administration authority (the SAT), the number of anonymous shell companies in the country has increased from 111 in 2014 to over 9,000 in 2020.

To crack down on the abuse of shell companies to embezzle public funds from the health sector (as well as other sectors), the authors of the Fake Invoices report propose three responses: Continue reading

Guest Post: What the U.S. Congress Must Do To Ensure Adequate Oversight of COVID-19 Relief Spending

Today’s guest post is by Shruti Shah, the President and CEO of the Coalition for Integrity, a civil society advocacy organization focused on corruption in the United States.

We are facing an unprecedented crisis, and governments around the world have responded with unprecedented actions. In the United States, Congress has responded to the economic disruption caused by the COVID-19 crisis with the $2 trillion CARES Act and the subsequent $484 billion replenishment; still more legislation, allocating even more money for crisis response, is under discussion. When this much money is in play, oversight and fraud prevention are essential. There are already reports of PPP loans meant for small businesses going to larger companies, scammers targeting small business owners, stimulus checks being sent to deceased people, and several other COVID 19 scams. But the current safeguards for preventing fraud, corruption, and abuse in COVID-19 relief spending are woefully insufficient. As negotiations over further relief packages continue, those in Congress who care about government integrity—and the effectiveness of these trillion-dollar programs in achieving their objectives—should insist on correcting these deficiencies. In particular, here are five crucial steps that Congress can and should take to ensure that COVID-19 relief spending helps its intended beneficiaries rather than lining the pockets of grifters and grafters: Continue reading

Guest Post: COVID-19 and Corruption–Two Risks and One Opportunity

Today’s guest post is from Peter Glover, Program officer for the Center for International Private Enterprise’s Anti-Corruption and Governance Center.

The immediate consequences of COVID-19 are visible and visceral for everybody, even as some feel the effects more than others. In addition to reshaping everyday life, COVID-19 will also transform global governance—including with respect to corruption and related issues. In this post I want to emphasize three ways that the COVID-19 pandemic will interact with corruption: Continue reading

Guest Post: Pushing for Anticorruption through the G20 Civil Society Engagement Process

Today’s guest post is from Blair Glencorse, the Executive Director of the Accountability Lab

As many readers of this blog know, the annual G20 meeting has a variety of associated processes, including a forum for engagement with global civil society known as the C20. This is an opportunity for civil society organizations (CSOs)—including grassroots groups, rights-focused organizations, and other activists—to feed policy recommendations directly to the most powerful governments in the world. This process has not been without challenges, especially when the G20 meeting is held in a country that is not exactly friendly to civil society activism (including Russia in 2013, China in 2016 and this year in Saudi Arabia). More generally, promises have not always matched realities, and governments have not always lived up to their commitments. Nevertheless, the C20 remains an important mechanism for ensuring that diverse, citizen-oriented voices from civil society are heard as part of G20 decision-making.

The C20 has a number of working groups, including an Anti-Corruption Working Group (ACWG), which I am co-leading this year with Dr. Saleh Al-Sheniefi. Our mandate is to prepare “comprehensive recommendations for consideration by leaders on how the G20 could continue to make practical and valuable contributions to international efforts to combat corruption.” The ACWG has active participation from civil society members from more than 50 countries, and—after consulting with other G20 engagement groups and consulted with numerous external experts—we have drafted a 3-page policy paper which will be sent to the parallel G20 Anti-Corruption Working Group in mid-May. The paper is open for comments for the next several weeks; and we would welcome any and all ideas from this blog’s readership.

While there are obviously many aspects of the corruption problem and its potential solutions that we could have addressed, we chose to focus on what we understand to be the G20’s main anticorruption priorities. (Our thinking is that, while getting the G20 to listen and live up to its commitments is always challenging at best, the odds are better if civil society’s recommendations align with the G20’s own sense of its top priorities in this area.) In particular, our policy paper focuses on the following items: Continue reading

Guest Post: Lessons from the Campaign for the UK Bribery Act

Today’s guest post is from Robert Barrington, who is currently Professor of Anti-Corruption Practice at the University of Sussex’s Centre for the Study of Corruption, and who previously worked for Transparency International’s UK chapter (as Director of External Affairs from 2008-2013, and as Executive Director from 2013-2019).

The United Kingdom Bribery Act (UKBA) was enacted into law just over a decade ago, on April 8th 2010. This overhaul of UK law on transnational bribery was the culmination of a dozen years of vigorous campaigning by civil society advocacy groups, including Transparency International’s UK chapter (TI-UK). I was TI-UK’s Director of External Affairs for the final couple of years of that campaign, and I thought it might be helpful to reflect on some of the key lessons we learned in the course of the campaign for the UKBA. I explored these issues at greater length in a lecture marking the tenth anniversary of the UKBA, but in this post I want to focus on three of the most important lessons that we learned from the campaign for the UKBA, lessons that I hope will be useful to other civil society organizations engaged in similar campaigns elsewhere. Continue reading